One of the more frequent (and frankly just) complaints) about IRBs is that they involve themselves to deeply in reviewing and often modifying the scientific design of a study, sometimes to the point of r adically re-writing the protocol. There are circumstances where the IRB does need to evaluate the scientific design, and there are other circumstances where it should not get involved in these questions. A look at the regulations provides little guidance. The question of... Read More